Literature DB >> 29119560

Prevalence and risk factors for autism spectrum disorder in epilepsy: a systematic review and meta-analysis.

Lauren Strasser1, Michelle Downes1, Jane Kung1, J Helen Cross1, Michelle De Haan1.   

Abstract

AIM: To assess the prevalence and risk factors for autism spectrum disorder (ASD) in epilepsy, and to better understand the relationship and comorbidity between these disorders.
METHOD: PsychINFO and PubMed were searched for articles published in the past 15 years that examined the prevalence of ASD in individuals with epilepsy.
RESULTS: A total of 19 studies were found with a pooled ASD prevalence of 6.3% in epilepsy. When divided by type, the risks of ASD for general epilepsy, infantile spasms, focal seizures, and Dravet syndrome were 4.7%, 19.9%, 41.9%, and 47.4% respectively. Studies with populations under 18 years showed a 13.2 times greater risk of ASD than study populations over 18 years, and samples with most (>50%) individuals with intellectual disability showed a greater risk 4.9 times higher than study populations with a minority of individuals with intellectual disability. The main risk factors for ASD reported in the 19 studies included presence of intellectual disability, sex, age, and symptomatic aetiology of epilepsy.
INTERPRETATION: Current research supports a high prevalence of ASD in epilepsy. This study helps to define the clinical profile of patients with epilepsy who are at risk for ASD, which may help clinicians in early screening and diagnosis of ASD in this population. WHAT THIS PAPER ADDS: Critical evaluation of previous studies examining the prevalence of autism spectrum disorder (ASD) in individuals with epilepsy. A meta-analysis of 19 studies showed a pooled ASD prevalence of 6.3% in individuals with epilepsy. Studies that included a majority of individuals with intellectual disability or younger population age had a higher prevalence of autism. Risk factors reported in studies included presence of intellectual disability, sex, age, and symptomatic epilepsy origin.
© 2017 Mac Keith Press.

Entities:  

Mesh:

Year:  2017        PMID: 29119560     DOI: 10.1111/dmcn.13598

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  20 in total

1.  Recovery from Autism after Successful Surgery for a Benign Brain Tumor Associated with Epilepsy.

Authors:  Michal Hrdlicka; Martin Kudr; Pavel Krsek; Michal Tichy; Martin Kyncl; Josef Zamecnik; Marketa Mohaplova; Iva Dudova
Journal:  J Autism Dev Disord       Date:  2019-12

2.  Mercury-associated diagnoses among children diagnosed with pervasive development disorders.

Authors:  David A Geier; Janet K Kern; Lisa K Sykes; Mark R Geier
Journal:  Metab Brain Dis       Date:  2018-03-06       Impact factor: 3.584

3.  An Unbiased Drug Screen for Seizure Suppressors in Duplication 15q Syndrome Reveals 5-HT1A and Dopamine Pathway Activation as Potential Therapies.

Authors:  Bidisha Roy; Jungsoo Han; Kevin A Hope; Tracy L Peters; Glen Palmer; Lawrence T Reiter
Journal:  Biol Psychiatry       Date:  2020-04-13       Impact factor: 13.382

Review 4.  Autistic traits in epilepsy models: Why, when and how?

Authors:  Jana Velíšková; Jill L Silverman; Melissa Benson; Pierre-Pascal Lenck-Santini
Journal:  Epilepsy Res       Date:  2018-05-18       Impact factor: 3.045

Review 5.  Epileptic disorders in Becker and Duchenne muscular dystrophies: a systematic review and meta-analysis.

Authors:  Carlos Pascual-Morena; Vicente Martínez-Vizcaíno; Alicia Saz-Lara; José Francisco López-Gil; Jaime Fernández-Bravo-Rodrigo; Iván Cavero-Redondo
Journal:  J Neurol       Date:  2022-03-01       Impact factor: 4.849

6.  The association between early childhood onset epilepsy and attention-deficit hyperactivity disorder (ADHD) in 3237 children and adolescents with Autism Spectrum Disorder (ASD): a historical longitudinal cohort data linkage study.

Authors:  Vibhore Prasad; Johnny Downs; Lauren Carson; Valeria Parlatini; Tara Safa; Benjamin Baig; Hitesh Shetty; Jacqueline Phillips-Owen
Journal:  Eur Child Adolesc Psychiatry       Date:  2022-08-04       Impact factor: 5.349

7.  TAU ablation in excitatory neurons and postnatal TAU knockdown reduce epilepsy, SUDEP, and autism behaviors in a Dravet syndrome model.

Authors:  Eric Shao; Che-Wei Chang; Zhiyong Li; Xinxing Yu; Kaitlyn Ho; Michelle Zhang; Xin Wang; Jeffrey Simms; Iris Lo; Jessica Speckart; Julia Holtzman; Gui-Qiu Yu; Erik D Roberson; Lennart Mucke
Journal:  Sci Transl Med       Date:  2022-04-27       Impact factor: 19.319

8.  Brief Report: The Characterization of Medical Comorbidity Prior to Autism Diagnosis in Children Before Age Two.

Authors:  Ekomobong E Eyoh; Michelle D Failla; Zachary J Williams; Kyle L Schwartz; Laurie E Cutting; Bennett A Landman; Carissa J Cascio
Journal:  J Autism Dev Disord       Date:  2021-12-01

9.  Chronic sodium bromide treatment relieves autistic-like behavioral deficits in three mouse models of autism.

Authors:  Julie Le Merrer; Jerome A J Becker; Cécile Derieux; Audrey Léauté; Agathe Brugoux; Déborah Jaccaz; Claire Terrier; Jean-Philippe Pin; Julie Kniazeff
Journal:  Neuropsychopharmacology       Date:  2022-04-13       Impact factor: 8.294

10.  Pathogenesis and pathophysiology of autosomal dominant sleep-related hypermotor epilepsy with S284L-mutant α4 subunit of nicotinic ACh receptor.

Authors:  Kouji Fukuyama; Masashi Fukuzawa; Takashi Shiroyama; Motohiro Okada
Journal:  Br J Pharmacol       Date:  2020-02-15       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.